177 related articles for article (PubMed ID: 10970368)
1. Experimental model of progressive disseminated trichosporonosis in mice with latent trichosporonemia.
Yamagata E; Kamberi P; Yamakami Y; Hashimoto A; Nasu M
J Clin Microbiol; 2000 Sep; 38(9):3260-6. PubMed ID: 10970368
[TBL] [Abstract][Full Text] [Related]
2. [Pathogenesis of Trichosporon asahii and strategies for infectious control of disseminated trichosporonosis].
Tokimatsu I; Karashima R; Yamagata E; Yamakami Y; Nagai H; Kadota J; Nasu M
Nihon Ishinkin Gakkai Zasshi; 2003; 44(3):181-6. PubMed ID: 12913806
[TBL] [Abstract][Full Text] [Related]
3. Identification of the first isolates of Trichosporon asahii var asahii from disseminated trichosporonosis in China.
Abliz P; Fukushima K; Takizawa K; Yang R; Li R; Nishimura K
Diagn Microbiol Infect Dis; 2002 Sep; 44(1):17-22. PubMed ID: 12376026
[TBL] [Abstract][Full Text] [Related]
4. Pathogenicity of Trichosporon asahii in a murine model of disseminated trichosporonosis.
Yang RY; Wang WL; Ao JH; Hao ZF; Zhang J; Wang CM
Chin Med J (Engl); 2008 Dec; 121(24):2557-60. PubMed ID: 19187595
[TBL] [Abstract][Full Text] [Related]
5. Experimental disseminated trichosporonosis in mice: tissue distribution and therapy with antifungal agents.
Yamamoto K; Makimura K; Sudo T; Shibuya K; Uchida K; Yamaguchi H
J Med Vet Mycol; 1997; 35(6):411-8. PubMed ID: 9467108
[TBL] [Abstract][Full Text] [Related]
6. PCR detection of DNA specific for Trichosporon species in serum of patients with disseminated trichosporonosis.
Nagai H; Yamakami Y; Hashimoto A; Tokimatsu I; Nasu M
J Clin Microbiol; 1999 Mar; 37(3):694-9. PubMed ID: 9986834
[TBL] [Abstract][Full Text] [Related]
7. In vivo pathogenicity of Trichosporon asahii isolates with different in vitro enzymatic profiles in an immunocompetent murine model of systemic trichosporonosis.
Montoya AM; Luna-Rodríguez CE; Treviño-Rangel RJ; Becerril-García M; Ballesteros-Elizondo RG; Saucedo-Cárdenas O; González GM
Med Mycol; 2018 Jun; 56(4):434-441. PubMed ID: 28992352
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic efficacy of posaconazole in a murine model of disseminated trichosporonosis.
Treviño-Rangel Rde J; López LJ; Palma-Nicolás JP; Hernández-Bello R; González JG; González GM
J Antimicrob Chemother; 2014 Apr; 69(4):1075-8. PubMed ID: 24252752
[TBL] [Abstract][Full Text] [Related]
9. Invasive trichosporonosis caused by Trichosporon asahii and other unusual Trichosporon species at a medical center in Taiwan.
Ruan SY; Chien JY; Hsueh PR
Clin Infect Dis; 2009 Jul; 49(1):e11-7. PubMed ID: 19489711
[TBL] [Abstract][Full Text] [Related]
10. [Fungemia due to Trichosporon asahii in a patient with hematological malignancy].
Odero V; Galán-Sánchez F; García-Agudo L; García-Tapia AM; Guerrero-Lozano I; Rodríguez-Iglesias MA
Rev Iberoam Micol; 2015; 32(1):59-61. PubMed ID: 24071639
[TBL] [Abstract][Full Text] [Related]
11. Autopsy case of disseminated Trichosporon inkin infection identified with molecular biological and biochemical methods.
Koyanagi T; Nishida N; Osabe S; Imamura Y; Yamamoto S; Shichiji A; Nakamura Y
Pathol Int; 2006 Dec; 56(12):738-43. PubMed ID: 17096731
[TBL] [Abstract][Full Text] [Related]
12. The prophylactic effectiveness of various antifungal agents against the progression of trichosporonosis fungemia to disseminated disease in a neutropenic mouse model.
Tokimatsu I; Kushima H; Hashinaga K; Umeki K; Ohama M; Ishii H; Kishi K; Hiramatsu K; Kadota J
Int J Antimicrob Agents; 2007 Jan; 29(1):84-8. PubMed ID: 17189098
[TBL] [Abstract][Full Text] [Related]
13. Switching of colony morphology and adhesion activity of Trichosporon asahii clinical isolates.
Ichikawa T; Yoshiyama N; Ohgane Y; Ikeda R
Med Mycol; 2016 Feb; 54(2):189-96. PubMed ID: 26483434
[TBL] [Abstract][Full Text] [Related]
14. [Recent knowledge allowing diagnosis and treatment of deep-seated trichosporonosis].
Yamakami Y; Yamagata E; Karashima R; Tokimatsu I; Kamberi P; Hashimoto A; Nagai H; Nasu M
Nihon Ishinkin Gakkai Zasshi; 2000; 41(4):235-9. PubMed ID: 11064321
[TBL] [Abstract][Full Text] [Related]
15. Fatal disseminated Trichosporon asahii fungemia in a child with acute lymphoblastic leukemia and a morbilliform eruption.
Nguyen JK; Schlichte MJ; Schady D; Pourciau CY
Pediatr Dermatol; 2018 Jan; 35(1):e86-e87. PubMed ID: 29266471
[TBL] [Abstract][Full Text] [Related]
16. [Emerging deep-seated fungal infection, trichosporonosis].
Tokimatsu I; Kadota J
Kansenshogaku Zasshi; 2006 May; 80(3):196-202. PubMed ID: 16780125
[TBL] [Abstract][Full Text] [Related]
17. The development of animal infection models and antifungal efficacy assays against clinical isolates of Trichosporon asahii, T. asteroides and T. inkin.
Mariné M; Bom VL; de Castro PA; Winkelstroter LK; Ramalho LN; Brown NA; Goldman GH
Virulence; 2015; 6(5):476-86. PubMed ID: 25751127
[TBL] [Abstract][Full Text] [Related]
18. Effects of macrophage colony-stimulating factor (M-CSF) on anti-fungal activity of mononuclear phagocytes against Trichosporon asahii.
Sasaki E; Tashiro T; Kuroki M; Seki M; Miyazaki Y; Maesaki S; Tomono K; Kadota J; Kohno S
Clin Exp Immunol; 2000 Feb; 119(2):293-8. PubMed ID: 10632665
[TBL] [Abstract][Full Text] [Related]
19. Development of a loop-mediated isothermal amplification assay for rapid detection of Trichosporon asahii in experimental and clinical samples.
Zhou J; Liao Y; Li H; Lu X; Han X; Tian Y; Chen S; Yang R
Biomed Res Int; 2015; 2015():732573. PubMed ID: 25692144
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of voriconazole in a guinea pig model of invasive trichosporonosis.
Serena C; Gilgado F; Mariné M; Pastor FJ; Guarro J
Antimicrob Agents Chemother; 2006 Jun; 50(6):2240-3. PubMed ID: 16723595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
